Clinical Trial Update: Trastuzumab in HER2-positive Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of trastuzumab in HER2-positive biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: Changhoon Yoo | Conditions: Cholangiocarcinoma, Biliary Tract Cancer | Phase 2 | Status: COMPLETED